doi: 10.3389/fphar.2024.1483792 Received 20 August 2024 Accepted 23 December 2024 Published 20 January 2025 Volume 15 - 2024 Edited by Ewa Krystyna Szczepanska-Sadowska, Medical University of Warsaw, Poland Reviewed by Per M
PMID: 39 AuduCOWolfSJJoshiADMoonJYMelvinWJSharmaSBet al
The results of this study of postmenopausal women indicate that CELLg8 SLEEP significantly improves sleep duration and decreases the number of awakenings, compared to placebo
Although previous studies have used nano-fluorescent probes to detect the cellular delivery efficiency of oligonucleotide molecules, 403,457,575 more pharmacokinetic data on biodistribution, immune compatibility, and toxicity are needed for clinical translation and practical therapeutic application of these systems
Reference link (FDA label PDF): Other narrow therapeutic index medicines (where small changes in absorption can matter) may warrant extra attention depending on the patient (examples often discussed for the GLP-1 class include warfarin or digoxinmonitoring decisions should be individualized)
Ulian MD, Unsain RF, Franco RR, Santo MA, Brewis A, Trainer S, et al